STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[6-K] Immatics N.V. Current Report (Foreign Issuer)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
6-K
Rhea-AI Filing Summary

Immatics N.V. (IMTX) submitted a Form 6-K to provide investors with an interim report for the three- and nine-month period ended September 30, 2025 and a related press release with its third quarter 2025 financial results and business update. The interim report is furnished as Exhibit 99.1 and the press release as Exhibit 99.2.

The interim report and Exhibit 99.1 are also incorporated by reference into Immatics' existing Form S-8 and Form F-3 registration statements, meaning those registration statements now include the updated information from this interim report.

Positive
  • None.
Negative
  • None.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

Pursuant to Rule 13a-16 or 15d-16

of the Securities Exchange Act of 1934

November 17, 2025

Commission File Number: 001-39363

IMMATICS N.V.

Paul-Ehrlich-Straße 15

72076 Tübingen, Federal Republic of Germany

(Address of Principal Executive Office)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F Form 40-F

 


 

 

INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K

On November 17, 2025, Immatics N.V. (the “Company”) issued an interim report for the three- and nine-month period ended September 30, 2025, which is attached hereto as Exhibit 99.1, and issued a press release announcing the third quarter 2025 financial results and business update for the Company, which is attached hereto as Exhibit 99.2.

 

INCORPORATION BY REFERENCE

This Report on Form 6-K (other than Exhibit 99.2 hereto) including Exhibit 99.1 hereto, shall be deemed to be incorporated by reference into the registration statements on Form S-8 (Registration Nos. 333-249408, 333-265820, 333-280935 and 333-288466) and the registration statements on Form F-3 (Registration Nos. 333-240260, 333-274218 and 333-286151) of Immatics N.V. and to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished.

EXHIBITS

 

 

Exhibit

Number

Description

99.1

Immatics N.V. interim report for the three- and nine-month period ended September 30, 2025.

99.2

Press release dated November 17, 2025.

 

 

 

2


 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

 

 

IMMATICS N.V.

Date: November 17, 2025

by:

/s/ Harpreet Singh

Harpreet Singh

Chief Executive Officer

 

3


FAQ

What did Immatics N.V. (IMTX) file in this Form 6-K?

Immatics N.V. filed a Form 6-K to furnish an interim report for the three- and nine-month period ended September 30, 2025 as Exhibit 99.1 and a press release with third quarter 2025 financial results and a business update as Exhibit 99.2.

Which periods are covered by Immatics N.V.'s latest interim report?

The interim report attached to the Form 6-K as Exhibit 99.1 covers the three- and nine-month period ended September 30, 2025.

How does this Form 6-K affect Immatics N.V.'s existing registration statements?

This Form 6-K, other than Exhibit 99.2, including Exhibit 99.1, is incorporated by reference into Immatics N.V.'s Form S-8 and Form F-3 registration statements, so those registration statements now include the information from this interim report.

What information is contained in Exhibit 99.2 for Immatics N.V. (IMTX)?

Exhibit 99.2 is a press release dated November 17, 2025 announcing Immatics N.V.'s third quarter 2025 financial results and providing a business update.

Who signed the Immatics N.V. Form 6-K dated November 17, 2025?

The Form 6-K was signed on behalf of Immatics N.V. by Harpreet Singh, the company's Chief Executive Officer.
Immatics N.V

NASDAQ:IMTX

IMTX Rankings

IMTX Latest News

IMTX Latest SEC Filings

IMTX Stock Data

1.25B
88.81M
22.85%
79.55%
2.95%
Biotechnology
Healthcare
Link
Germany
Tübingen